GCKR: Glucokinase Regulator

Key regulator of hepatic glucose metabolism and lipid homeostasis

Gene Information Card

Symbol GCKR
Full Name Glucokinase Regulator
Gene Type Protein coding
Chromosomal Location 2p23.3
NCBI Gene ID 2646 ncbi.nlm.nih.gov/gene/2646
Ensembl ID ENSG00000184727
UniProt ID Q14397
OMIM ID 600842
HGNC ID 4196
Aliases GKRP, glucokinase regulatory protein

Description

The GCKR gene encodes the glucokinase regulatory protein (GKRP), a 68-kDa protein predominantly expressed in the liver. GKRP binds to and inhibits glucokinase (GCK) in the nucleus, sequestering it from the cytoplasm. Upon glucose influx, GKRP dissociates, releasing active GCK to phosphorylate glucose, thereby regulating hepatic glucose uptake and glycogen synthesis. GCKR variants influence fasting glucose, triglycerides, and risk for metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Maturity-Onset Diabetes of the Young (MODY) GCKR mutations alter GKRP-GCK interaction, impairing glucose sensing and insulin secretion; rare variants cause MODY-like phenotypes. ClinVar, OMIM
Hypertriglyceridemia, familial Common GCKR variants (e.g., rs1260326) reduce GKRP inhibition, increasing GCK activity and hepatic lipogenesis, elevating triglycerides. ClinVar, NCBI
Type 2 Diabetes GCKR polymorphisms modulate fasting glucose and insulin sensitivity; genome-wide association studies link rs780094 to T2D risk. NCBI, OMIM

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Pancreas 0.8 Low
Kidney 0.3 Not detected
Small intestine 0.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 Hepatocellular carcinoma cell line; high expression
Huh7 13.8 Hepatoma cell line; high expression
HEK293 0.5 Embryonic kidney; very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs1260326 (c.1337C>T, p.Pro446Leu) SNP ~40% (global) Reduces GKRP inhibition of GCK; associated with lower fasting glucose and higher triglycerides.
rs780094 (intronic) SNP ~35% (global) Linked to altered GCKR expression; associated with T2D and hypertriglyceridemia.
c.94G>A (p.Gly32Arg) Missense <0.1% Rare; disrupts GKRP-GCK binding; reported in MODY families.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., nonsense, frameshift) reduce GKRP expression or binding, leading to unregulated GCK activity, hypoglycemia, and increased lipogenesis.

Gain of Function (GOF)

Gain-of-function mutations enhance GKRP inhibition of GCK, causing hyperglycemia and reduced triglyceride synthesis; rare.

Dominant Negative (DN)

Dominant-negative variants (e.g., p.Gly32Arg) produce defective GKRP that sequesters GCK but fails to release it, impairing glucose sensing.

Pathways

Glucokinase regulation in liver
Glycolysis and gluconeogenesis
Insulin signaling
Lipid metabolism

Protein Summary

Glucokinase regulatory protein (GKRP) is a 626-amino acid protein that forms a complex with glucokinase (GCK) in the hepatocyte nucleus. It inhibits GCK by binding to its active site, and this inhibition is relieved by fructose-1-phosphate. GKRP acts as a glucose sensor, modulating hepatic glucose flux. Its structure includes a sugar-binding domain and a GCK-binding region. Post-translational modifications include phosphorylation, which affects stability.

Related Products

Product name Cat.No. Species Gene ID
GCKR Knockout HEK293 Cell Line EDJ-KQ4693 Human 2646 Details Get a Quote
GCKR Knockout HeLa Cell Line EDJ-KQ53318 Human 2646 Details Get a Quote
GCKR Knockout A-549 Cell Line EDJ-KQ61801 Human 2646 Details Get a Quote
GCKR Knockout HCT 116 Cell Line EDJ-KQ70286 Human 2646 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: